Disruption of disulfide linkages of the Plasmodium falciparum circumsporozoite protein: effects on cytotoxic and antibody responses in mice.

[1]  J. Sidney,et al.  HLA-A*01-Restricted Cytotoxic T-Lymphocyte Epitope from the Plasmodium falciparum Circumsporozoite Protein , 2001, Infection and Immunity.

[2]  B. F. Hall,et al.  Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. , 2000, The Journal of infectious diseases.

[3]  T. McCutchan,et al.  Role of cysteines in Plasmodium falciparum circumsporozoite protein: interactions with heparin can rejuvenate inactive protein mutants. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Sercarz,et al.  Processing and Reactivity of T Cell Epitopes Containing Two Cysteine Residues from Hen Egg-White Lysozyme (HEL74–90)1 , 2000, The Journal of Immunology.

[5]  T. McCutchan,et al.  The Cytotoxic T-Lymphocyte Epitope of the Plasmodium falciparum Circumsporozoite Protein Also Modulates the Efficiency of Receptor-Ligand Interaction with Hepatocytes , 2000, Infection and Immunity.

[6]  S. Hoffman,et al.  Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. , 1998, Science.

[7]  S. Hoffman,et al.  In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. , 1998, International journal of molecular medicine.

[8]  P. Sinnis,et al.  Anopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum. , 1997, Molecular and biochemical parasitology.

[9]  A. Holder,et al.  Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds , 1997, Infection and immunity.

[10]  R W Chesnut,et al.  Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.

[11]  E. Wherry,et al.  Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. , 1997, Journal of immunology.

[12]  R. Ménard,et al.  Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes , 1997, Nature.

[13]  Joe D. Cohen,et al.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.

[14]  X. Liang,et al.  An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. , 1997, The Journal of infectious diseases.

[15]  H. Davis,et al.  DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Tolle,et al.  Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors. , 1996, The American journal of tropical medicine and hygiene.

[17]  E. Paoletti,et al.  NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria , 1996, Infection and immunity.

[18]  S. Hoffman,et al.  Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity , 1996, The Journal of experimental medicine.

[19]  S. Hoffman.  Malaria vaccine development: a multi-immune response approach , 1996 .

[20]  S. Hoffman,et al.  Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein. , 1995, Molecular immunology.

[21]  N. Shastri,et al.  Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. , 1995, Journal of immunology.

[22]  S. Hoffman,et al.  Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein , 1995, Infection and immunity.

[23]  A. Hill,et al.  Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria , 1995, The Lancet.

[24]  D. Valmori,et al.  Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. , 1995, Journal of immunology.

[25]  A. Holder,et al.  Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum , 1995, Infection and immunity.

[26]  S. Bertholet,et al.  Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides. , 1994, Journal of immunology.

[27]  S. Hoffman,et al.  Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Hoffman,et al.  Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant , 1993, Infection and immunity.

[29]  S. Hoffman,et al.  Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. , 1993, The American journal of tropical medicine and hygiene.

[30]  M. Alpers,et al.  Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein , 1993, Infection and immunity.

[31]  V. Nussenzweig,et al.  Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes , 1993, The Journal of experimental medicine.

[32]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[33]  C. Locher,et al.  Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodies. , 1993, Vaccine.

[34]  M. Aidoo,et al.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.

[35]  D. Stüber,et al.  Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers. , 1992, Journal of immunology.

[36]  H. Webster,et al.  Characterization of naturally acquired antibodies to the non-repetitive flanking regions of the circumsporozoite protein of Plasmodium falciparum. , 1992, The American journal of tropical medicine and hygiene.

[37]  V. Nussenzweig,et al.  The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of plasmodium falciparum sporozoites , 1992, Cell.

[38]  S. Hoffman,et al.  A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. , 1992, Journal of immunology.

[39]  P. Romero,et al.  CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. , 1991, International immunology.

[40]  S. Hoffman,et al.  Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Romero,et al.  Isolation and characterization of protective cytolytic T cells in a rodent malaria model system. , 1990, Immunology letters.

[42]  R. Meloen,et al.  New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein , 1990, European journal of immunology.

[43]  V. Nussenzweig,et al.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.

[44]  J. Berzofsky,et al.  Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum , 1988, Nature.

[45]  Andrew Pollard,et al.  DEATHS DURING MOUNTAINEERING AT EXTREME ALTITUDE , 1988, The Lancet.

[46]  F. Bonelli,et al.  Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice. , 1988, Immunology.

[47]  V. Nussenzweig,et al.  γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.

[48]  Myron M. Levine,et al.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites , 1987, Nature.

[49]  S. Hoffman,et al.  SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE , 1987, The Lancet.

[50]  V. Nussenzweig,et al.  Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes , 1983, The Journal of experimental medicine.

[51]  V. Nussenzweig,et al.  Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax , 1982, The Journal of experimental medicine.

[52]  S. Rosenberg,et al.  A simplified method for the production of murine T-cell growth factor free of lectin. , 1981, Journal of immunological methods.

[53]  J. Vanderberg,et al.  Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.